Lung Cancer News

The likelihood for lung cancer screening uptake was reduced among current vs. never e-cigarette users, according to results published in JAMA Network Open.

Adjuvant durvalumab failed to improve outcomes compared with placebo for certain patients with early-stage lung cancer, according to the agent’s manufacturer.

The risk for lung cancer has been found to be particularly high in some Maryland counties, but a recently launched initiative is making sure screening is available for all eligible state residents, according to a press release.

Potential risk factors for lung cancer reoccurrence within 2 years include obstructive sleep apnea-related episodic hypoxemia and hypoxic burden, according to research presented at SLEEP 2024.

Discussion about lung cancer research breakthroughs dominated the social media conversation among health care professionals during this year’s ASCO Annual Meeting.

SAN DIEGO — More than 75% of individuals who underwent lung cancer screening without a reported history of COPD had airways disease, according to research presented at the American Thoracic Society International Conference.

CHICAGO — A stepped palliative care model delivering early care at key points for patients with advanced cancer resulted in fewer visits while still maintaining quality-of-life benefits, results from a randomized study showed.

CHICAGO — Individuals with KRAS-mutant lung cancer treated with adagrasib experienced significantly prolonged PFS compared with docetaxel, randomized study results presented at ASCO Annual Meeting showed.

CHICAGO — The addition of subcutaneous amivantamab to lazertinib demonstrated noninferior pharmacokinetics and objective response rate compared with intravenous amivantamab, results from a phase 3 study showed.

SAN DIEGO — Fewer patients with lung nodules had complications during a navigational bronchoscopy procedure vs. a CT-guided biopsy, according to research presented at the American Thoracic Society International Conference.